Page 51 - Read Online

Page 16 of 16 Weidner et al. J Transl Genet Genom 2019;3:2. I https://doi.org/10.20517/jtgg.2018.30

113. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. Circulating microRNAs as stable blood-based markers for cancer detection.
Proc Natl Acad Sci U S A 2008;105:10513-8.
114. Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 2012;32:326-48.
115. Bouchie A. First microRNA mimic enters clinic. Nat Biotechnol 2013;31:577.
116. Ørum H. Locked nucleic acids as microRNA therapeutics. In: Lawrie CH, editor. MicroRNAs in medicine. John Wiley & Sons: Inc; 2013.
pp. 663-72.
117. Rai K, Takigawa N, Ito S, Kashihara H, Ichihara E, et al. Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal
growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells. Mol Cancer Ther 2011;10:1720-7.
118. Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid
emulsion inhibits lung tumors in mice. Mol Ther 2011;19:1116-22.
119. van Zandwijk N, Pavlakis N, Kao SC, Linton A, Boyer MJ, et al. Safety and activity of microRNA-loaded minicells in patients with
recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. Lancet Oncol 2017;18:1386-96.
120. Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, et al. DIANA-miRPath v3.0: deciphering microRNA
function with experimental support. Nucleic Acids Res 2015;43:W460-6.
121. Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res 2016;44:D239-47.
122. Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-
target interactions. Nucleic Acids Res 2018;46:D296-302.
123. Lee YJ, Kim V, Muth DC, Witwer KW. Validated microRNA target databases: an evaluation. Drug Dev Res 2015;76:389-96.